Liver TransplantationLiving DonorsLiver FailureTissue DonorsGraft SurvivalCadaverHepatic VeinsLiver DiseasesTacrolimusGraft RejectionImmunosuppressive AgentsPostoperative ComplicationsAnastomosis, SurgicalTreatment OutcomeRetrospective StudiesPortal VeinTissue and Organ ProcurementLiverEnd Stage Liver DiseaseHepatectomyLiver CirrhosisDonor SelectionLiver NeoplasmsWaiting ListsTissue and Organ HarvestingTransplantsKidney TransplantationTime FactorsTransplantationLiver Function TestsLiver CirculationLiver RegenerationHepatic ArteryTransplantation, HomologousLiver Failure, AcuteBiliary AtresiaBiliary Tract DiseasesFatty LiverBlood DonorsImmunosuppressionCarcinoma, HepatocellularCyclosporineBile DuctsMycophenolic AcidPatient SelectionRisk FactorsBiliary Tract Surgical ProceduresHepatitis CPostoperative PeriodFollow-Up StudiesRecurrenceSurvival RateCold IschemiaMicrosomes, LiverHeart TransplantationRisk AssessmentCholestasisReoperationDeathConstriction, PathologicSurvival AnalysisBrain DeathCytomegalovirus InfectionsBiopsyKaplan-Meier EstimateBlood Group IncompatibilityReconstructive Surgical ProceduresABO Blood-Group SystemAlanine TransaminaseBiliary TractHistocompatibility TestingTransplantation ImmunologyOrgan Preservation SolutionsCholangitis, SclerosingFatal OutcomeBile Duct DiseasesAntiviral AgentsDrug-Induced Liver InjuryOrgan SizeProspective StudiesHealth Care RationingOrgan PreservationIncidenceLung TransplantationVena Cava, InferiorHepatitis BBilirubinTomography, X-Ray ComputedAmyloid Neuropathies, FamilialMitochondria, LiverLiver Cirrhosis, AlcoholicBone Marrow TransplantationMultivariate AnalysisTransplantation ToleranceSeverity of Illness IndexProportional Hazards ModelsLiver Diseases, AlcoholicCohort StudiesWarm IschemiaRaffinose